Log in to save to my catalogue

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_762481171

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis

About this item

Full title

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Drug discovery, 2010-11, Vol.9 (11), p.883-897

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Key Points
Multiple sclerosis (MS) is a chronic, autoimmune disorder of the central nervous system (CNS) that is characterized by inflammation leading to astrogliosis, demyelination and oligodendrocyte and neuronal loss.
Current treatment strategies in MS involve management of symptoms and use of disease-modifying drugs, all of which must be...

Alternative Titles

Full title

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_762481171

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_762481171

Other Identifiers

ISSN

1474-1776

E-ISSN

1474-1784

DOI

10.1038/nrd3248

How to access this item